|
MX2016013265A
|
|
Analogues of 4h-pyrazolo[1,5-a]benzimidazole compound as parp inhibitors.
|
|
CN104370825A
|
|
Substituted heterocyclic compound as kinase inhibitor and its preparation method and use
|
|
CN104224690A
|
|
Meisuoshuli gel, and preparation method and use thereof
|
|
CN104237399A
|
|
Method for detecting ambrisenta crud materials and content of ambrisenta active ingredients in preparations
|
|
CN104237432A
|
|
Method for analyzing ambrisenta and content of ambrisenta in preparations by virtue of high-performance liquid chromatography
|
|
CN104127369A
|
|
Tacrolimus ointment and preparation method thereof
|
|
CN104086551A
|
|
Compounds and preparing method and applications thereof
|
|
WO2015158025A1
|
|
Compound and preparation method therefor and uses thereof
|
|
CN103910735A
|
|
Pyrazolopyrimidinone compound and derivative as well as preparation method and application thereof
|
|
CN104876890A
|
|
A preparing process of a compound
|
|
CN104876889A
|
|
A synthesis method of a compound
|
|
CN104876930A
|
|
A synthesis method of a compound
|
|
CN104876995A
|
|
A preparing method of a chenodeoxycholic acid derivative
|
|
CN103852530A
|
|
Method for measuring content of superhelix DNA
|
|
CN103655486A
|
|
Sirolimus micro-emulsion particles and preparation method and application thereof
|
|
CN103893258A
|
|
Oral solid preparation containing desmodium styracifolium general flavone and application thereof
|
|
CN103893246A
|
|
General flavanone capsule of desmodium styracifolium and preparation method and application thereof
|
|
CN103893247A
|
|
Pharmaceutical composition as well as preparation method and application thereof
|
|
CN103664788A
|
|
Method for preparing medetomidine
|
|
CN103553984A
|
|
2-(4'-methoxy phenoxy)-4-nitro methanesulfonanilide crystal form and preparation method thereof
|
